Watch List – Johnson & Johnson (NYSE:JNJ) Zion Oil & Gas, Inc. (NASDAQ:ZN)
Trading the news is a technique to trade equities, currencies and other financial instruments on the financial markets. Trading news releases can be a noteworthy tool for financial shareholders. Economic news reports often drive strong short-term moves in the markets, which may create trading opportunities for traders. Declarations about corporate profits, a change in administration, rumors of a merger, are events that can cause a company’s share price to move wildly up or down. Interest rates, unemployment and export rates, or the central bank’s policy shifts, can cause a deep change of an exchange rate.
Danish biotech company Bavarian Nordic has expanded its partnership with Janssen Pharmaceuticals, a unit of Johnson & Johnson, to also grant the U.S. drugmaker the exclusive rights to its MVA-BN technology for vaccine programmes targeting hepatitis B and HIV-1.
Shares of Johnson & Johnson (NYSE:JNJ) declined -0.09% to $130.83 on Thursday. The stock price floated in a range of $129.57 – 131.15. The stock moved on high volume, traded at a volume of 5,838,110 shares, as compared to its average daily volume of 5.71M shares. The market capitalization for the company is reported at $352.43B.
Bavarian said the total potential deal value was up to $879 million counting upfront, equity investment and milestone payments. The Danish company raised its expectations for the year-end cash preparedness to around 2.6 billion Danish crowns ($409.99 million) from 2.4 billion crowns
Bavarian Nordic chief executive Paul Chaplin said the agreement built upon science and data “which has shown the potential that a combination of our two platforms could serve many patients in a wide range of disease areas.”
The two companies already have an ongoing partnership to develop vaccines for HPV and Ebola.
Johnson & Johnson will subscribe for $33 million worth of Bavarian Nordic shares as part of the new agreement, the Danish company said. (Source: Reuters)
Zion Oil & Gas, Inc. (NASDAQ:ZN) declined -0.71 points or -17.15% at the market. The stock opened at $4.04. It reached an intraday trading high of $4.10 and closed at $3.43. The total volume traded for the day is 3,382,402, as compared to its average daily volume of 1.53M shares. Trading volume, or volume, is the number of shares or contracts that point towards the overall activity of a security or market for a given period. Trading volume is a key technical indicator an investor uses to identify momentum in a stock and confirm a trend or trend reversal. Volume gives an investor an idea of the price action of a security and whether he should buy or sell the security.
Trading volume can also signal when an investor should take profits and sell a security because of low activity. If there is no relationship between the trading volume and the price of a security, this signals weakness in the current trend and a possible reversal.
The current EPS for the company has been recorded at $-0.24 and the beta value recorded by the company stands at 1.03 points.